# Cervical Cytology DNA Methylation for Cervical Cancer Screening

> **NCT06557954** · — · NOT_YET_RECRUITING · sponsor: **Lei Li** · enrollment: 30000 (estimated)

## Conditions studied

- Cervical Cancer
- DNA Methylation
- Cytology
- Human Papillomavirus Infection
- Cervical Intraepithelial Neoplasia
- Cancer Screening

## Interventions

- **DIAGNOSTIC_TEST:** human PAX1 and JAM3 gene methylation assays (PAX1m/JAM3m)

## Key facts

- **NCT ID:** NCT06557954
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 30000 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557954, "Cervical Cytology DNA Methylation for Cervical Cancer Screening". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06557954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*